Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralizationJing Yang, Guangwen Lu, Liyan Guo et al.|PLoS Pathogens|2023Cited by 16
A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate BindingJing Yang, Guangwen Lu, Sheng Lin et al.|Frontiers in Immunology|2022Cited by 10